Ashwagandha vs Magnesium
Both are commonly discussed for sleep and anxiety & stress and immune health. Ashwagandha and Magnesium both have moderate evidence — Ashwagandha edges ahead on research volume (20 vs 20 studies referenced).
Evidence last reviewed May 2026
Ashwagandha recommends stacking with Magnesium: Both are associated with stress reduction and improved sleep quality; combining them may support relaxation and HPA-axis regulation synergistically.
Ashwagandha
Adaptogen
Magnesium
Mineral
Evidence
🟡Moderate Evidence
🟡Moderate Evidence
Research says
Research agrees
Research agrees
Expert mentions
356
3 recommend
315
4 recommend
Studies
20
referenced
20
referenced
Study dose
300–600mg
The majority of positive RCTs and the meta-analytic evidence supporting stress and anxiety reduction used standardized extracts (e.g., KSM-66 or Sensoril) in the range of 300–600 mg per day, administered as a single dose or split across two doses; higher withanolide standardization (≥5%) is associated with the studied effects.
200–400mg
Studies and expert sources consistently reference 200–400 mg of elemental magnesium daily; the required capsule dose varies significantly by form, as elemental magnesium content differs — for example, magnesium glycinate is roughly 14% elemental magnesium, meaning a 400 mg capsule delivers only ~56 mg elemental magnesium.
Best timing
MorningEveningWith food
EveningWith food
Who recommends
Caution
Generally safe
Generally safe
Ashwagandha
Key findings
- ·Multiple RCTs and at least one meta-analysis support statistically significant reductions in perceived stress and anxiety with ashwagandha supplementation, making this the best-evidenced use case.
- ·Cortisol reduction has been reported across several placebo-controlled trials, suggesting a plausible biological mechanism underlying the stress-relief effects.
- ·Doses of 300–600 mg per day of standardized extract, consistent with those used in positive clinical trials, are referenced across the reviewed literature as the studied therapeutic range.
Evidence gaps
- ·Long-term safety data beyond 12 weeks is largely absent, leaving the risk profile for extended supplementation — including liver health — poorly characterized.
- ·Most trials use proprietary or specific extract formulations, making it unclear whether findings generalize to the wide variety of ashwagandha products available to consumers.
Magnesium
Key findings
- ·A strong-quality meta-analysis found oral magnesium supplementation improved sleep outcomes in older adults with insomnia, partially supporting claims about magnesium's role in sleep quality and onset.
- ·A strong-quality meta-analysis found magnesium supplementation positively affected glucose metabolism parameters in people with or at risk of type 2 diabetes, suggesting metabolic benefits in at-risk populations.
- ·Moderate-quality reviews support a role for magnesium in migraine prevention and in cardiovascular and cardiometabolic health, though causality and effect sizes require further confirmation.
Evidence gaps
- ·Most evidence comes from older adults or clinically deficient populations; it remains unclear whether magnesium supplementation benefits healthy individuals with adequate baseline magnesium levels.
- ·Form-specific clinical outcome data (e.g., glycinate, threonate, malate) is largely absent from high-quality trials, making it impossible to definitively recommend one form over another for specific outcomes like sleep or cognition.